期刊文献+

Biliary tract cancer stem cells-translational options and challenges

下载PDF
导出
摘要 Management of biliary tract cancer remains challenging. Tumors show high recurrence rates and therapeutic resistance, leading to dismal prognosis and short survival. The cancer stem cell model states that a tumor is a heterogeneous conglomerate of cells, in which a certain subpopulation of cells-the cancer stem cells-possesses stem cell properties. Cancer stem cells have high clinical relevance due to their potential contributions to development, progression and aggressiveness as well as recurrence and metastasis of malignant tumors. Consequently, reliable identification of as well as pharmacological intervention with cancer stem cells is an intensively investigated and promising research field. The involvement of cancer stem cells in biliary tract cancer is likely as a number of studies demonstrated their existence and the obvious clinical relevance of several established cancer stem cell markers in biliary tract cancer models and tissues. In the present article, we review and discuss the currently available literature addressing the role of putative cancer stem cells in biliary tract cancer as well as the connection between known contributors of biliary tract tumorigenesis such as oncogenic signaling pathways, micro-RNAs and the tumor microenvironment with cancer stem cells. Management of biliary tract cancer remains challenging. Tumors show high recurrence rates and therapeutic resistance, leading to dismal prognosis and short survival. The cancer stem cell model states that a tumor is a heterogeneous conglomerate of cells, in which a certain subpopulation of cells - the cancer stem cells - possesses stem cell properties. Cancer stem cells have high clinical relevance due to their potential contributions to development, progression and aggressiveness as well as recurrence and metastasis of malignant tumors. Consequently, reliable identification of as well as pharmacological intervention with cancer stem cells is an intensively investigated and promising research field. The involvement of cancer stem cells in biliary tract cancer is likely as a number of studies demonstrated their existence and the obvious clinical relevance of several established cancer stem cell markers in biliary tract cancer models and tissues. In the present article, we review and discuss the currently available literature addressing the role of putative cancer stem cells in biliary tract cancer as well as the connection between known contributors of biliary tract tumorigenesis such as oncogenic signaling pathways, micro-RNAs and the tumor microenvironment with cancer stem cells.
出处 《World Journal of Gastroenterology》 SCIE CAS 2017年第14期2470-2482,共13页 世界胃肠病学杂志(英文版)
基金 Supported by Studies of the authors Mayr C,Pichler M,Neureiter D and Kiesslich T in the research field of this review were supported by research grants of the Jubilaumsfonds derosterreichischen Nationalbank,No.12677 and No.14842 the research fund of the Paracelsus Medical University Salzburg,No.08/07/037,No.A-12/02/006-KIE and No.R-16/03/083-MAY
  • 相关文献

参考文献4

二级参考文献137

  • 1RenQingFENG LiYingDU ZhenQuanGUO.In vitro cultivation and differentiation of fetal liver stem cells from mice[J].Cell Research,2005,15(5):401-405. 被引量:9
  • 2Amalia Azzariti,Letizia Porcelli,Jian-Ming Xu,Grazia Maria Simone,Angelo Paradiso.Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib(Iressa^(TM))and to the antiangiogenic agent ZD6474:Cytotoxic and biomolecular effects[J].World Journal of Gastroenterology,2006,12(32):5140-5147. 被引量:1
  • 3Moserle, L., Ghisi, M., Amadori, A., Indraccolo, S., 2010. Side population and cancer stem cells: therapeutic implications Cancer Lett., 288(1):1-9. [doi:10.1016/j.canlet.2009.05.020].
  • 4Petersen, O.W., Nielsen, H.L., Gudjonsson, T., Villadsen, R., Rank, F., Niebuhr, E., Bissell, M.J., Ronnov-Jessen, L., 2003. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am. J. Pathol., 162(2):391-402. [doi:10.1016/SO002-9440(10)63834-5].
  • 5Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D,, Pilotti, S., Pierotti, M.A., Daidone, M.G., 2005. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. CancerRes., 65(13):5506-5511. [doi:10.1158/0008-5472. CAN-05-0626].
  • 6Pure, E., 2009. The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer. Expert Opin. Ther. Tar., 13(8):967-973. [doi:10.1517/14728220903103841].
  • 7Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D., Dirks, P.B. 2004. Identification of human brain tumour initiating cells. Nature, 432(7015):396-401. [doi:10.1038/nature 03128].
  • 8Vander Griend, D.J., Karthaus, W.L., Dalrymple, S., Meeker, A., DeMarzo, A.M., Isaacs, J.T., 2008. The role of CD133 in normal human prostate stem cells and malignant cancerinitiating cells. Cancer Res., 68(23):9703-9711. [doi:10. 1158/0008-5472.CAN-08-3084].
  • 9Wang, M., Qin, R.Y., Shen, M., Jiang, J.X., Hu, J., Du, Z.Y., Shi, J.C., 2009. Cancer stern cell marker CD24, CD44, ESA and CD34 expression in biliary tract tumors. Chin. J. Exp. Surg., 26(12): 1607-1609.
  • 10Yu, S.C., Ping, Y.F., Yi, L., Zhou, Z.H., Chen, J.H., Yao, X.H., Gao, L., Wang, J.M., Bian, X.W., 2008. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett., 265(1): 124-134. [doi:10.1016/j.eanlet.2008.02.010].

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部